Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial-Reference-Cited by-同舟云学术

Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial

Published:2024-04-30 Issue:6 Volume:41 Page:2500-2518
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Rejnmark Lars,Gosmanova Elvira O.,Khan Aliya A.,Makita Noriko,Imanishi Yasuo,Takeuchi Yasuhiro,Sprague Stuart,Shoback Dolores M.,Kohlmeier Lynn,Rubin Mishaela R.,Palermo Andrea,Schwarz Peter,Gagnon Claudia,Tsourdi Elena,Zhao Carol,Makara Michael A.,Ominsky Michael S.,Lai Bryant,Ukena Jenny,Sibley Christopher T.,Shu Aimee D.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12325-024-02843-8.pdf

Reference23 articles.

1. Shoback DM, Bilezikian JP, Costa AG, et al. Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab. 2016;101(6):2300–12.

2. Khan AA, Bilezikian JP, Brandi ML, et al. Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop. J Bone Miner Res. 2022;37(12):2568–85.

3. Gosmanova EO, Houillier P, Rejnmark L, Marelli C, Bilezikian JP. Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review: renal disease in chronic hypoparathyroidism. Rev Endocr Metab Disord. 2021;22(2):297–316.

4. Gosmanova EO, Chen K, Rejnmark L, et al. Risk of chronic kidney disease and estimated glomerular filtration rate decline in patients with chronic hypoparathyroidism: a retrospective cohort study. Adv Ther. 2021;38(4):1876–88.

5. Gosmanova EO, Ayodele O, Chen K, et al. Association of calcium and phosphate levels with incident chronic kidney disease in patients with hypoparathyroidism: a retrospective case–control study. Int J Endocrinol. 2022;2022:6078881.